Jeff Calcagno

Jeff Calcagno, MD, Principal, Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 2013. He is based in Silicon Valley, California. Dr. Calcagno came to Johnson & Johnson in 2011 and held roles in the Corporate Office of Science & Technology and the California Innovation Center. He has over two decades of healthcare and business experience: as a clinician, management consultant, research analyst, entrepreneur, and venture investor. Dr. Calcagno began his business career as a management consultant at McKinsey & Company. He later served as a healthcare research analyst at JP Morgan Hambrecht & Quist. As an entrepreneur, he ran corporate development and operations for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company. From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management. Dr. Calcagno graduated Phi Beta Kappa in Biology from Harvard College and earned an MD from Harvard Medical School, where he was a Rotary International Ambassadorial Scholar. He completed his medical-psychiatric internship and psychiatry residency at UCLA’s Neuropsychiatric Institute, served as program chief resident, and was awarded and completed a clinical neuropharmacology fellowship.